eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Submit a Response to This Article
No eLetters have been published for this article.
Article Tools
- Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors
Resistance to PI3K inhibitors in triple-negative breast cancer is mediated by AKT reactivation by the ubiquitin ligase Skp2.